The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Research output: Contribution to journalJournal articleResearchpeer-review

Cloud-based technologies, big data, statistical signal processing algorithms, and Artificial Intelligence (AI) technologies are expected to play an increasingly important role in themedical field. Big data and AI-technologies rely on the cloud for data storage as well as for computational power and thus need effective and robust legal frameworks for international data transfer. Because of inconsistent data protection regulations, this is not always simple to achieve as it can be illustrated in the United States (US)–European Union (EU) context. Due to the lack of general data protection law at the federal level, the US currently does not have a general ‘adequacy decision’ from the European Commission (EC) to enable EU-US crossborder data transfers without the need for additional data protection safeguards under GDPR. As a fallback, a ‘limited adequacy’ decision was adopted in 2016 on the so-called ‘EU/US Privacy Shield Framework’. This framework protects the fundamental rights of natural persons in the EU and allows the free transfer of personal data to companies that are certified under the EU-US Privacy Shield. However, the EU-US Privacy Shield has been recently contested at the Court of Justice of the European Union (CJEU). This paper analyzes the EUUS
Privacy Shield Framework, the associated legal challenges, and how these might affect organizations deploying or implementing cloud-basedmedical technologies relying on crossborder data transfers from EU data subjects.

Original languageEnglish
JournalEuropean Pharmaceutical Law Review
Issue number1
Pages (from-to)34 - 50
Number of pages19
Publication statusPublished - 25 Mar 2020

ID: 230518025